Otonomy to Participate in Two Upcoming Investor Conferences
March 05 2019 - 7:30AM
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that David A. Weber, Ph.D., president
and chief executive officer, is scheduled to participate in two
upcoming investor conferences:
- A presentation at the Cowen and Company 39th Annual Health Care
Conference in Boston on March 12, 2019 at 12:00 p.m. ET (9:00 a.m.
PT)
- Institutional investor meetings at the Oppenheimer 29th Annual
Healthcare Conference in New York on March 20, 2019.
A live audio webcast of the Cowen and Company Health Care
Conference presentation will be available through the Events and
Presentations page of the company's website (www.otonomy.com).
About Otonomy
Otonomy is a biopharmaceutical company dedicated to the
development of innovative therapeutics for neurotology. The company
pioneered the application of drug delivery technology to the ear in
order to develop products that achieve sustained drug exposure from
a single local administration. This approach is covered by a broad
patent estate and is being utilized to develop a pipeline of
products addressing important unmet medical needs including
Ménière’s disease, hearing loss, and tinnitus. For additional
information please visit www.otonomy.com.
Contacts:
Media Inquiries Spectrum Leticia Diaz Vice President
202.587.2517 ldiaz@spectrumscience.com
Investor InquiriesWestwicke PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024